ZVRA Zevra Corp: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan

Simbol resmi perusahaan Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics (ZVRA) demonstrates recession resilience through the commercialization of orphan drugs. The quarterly EPS change reflects the clarity of the fundamental trend, recording the metric at 2772.80. Growth is supported by partnerships with scientific foundations to identify new molecular applications. Operational stability is ensured by an asset-light model, outsourcing capsule production to specialized contract manufacturing organizations.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Zevra Therapeutics, Inc. (ZVRA): kanggo periode 28.04.2023 - 17.11.2026

Rincian analitis perusahaan Zevra Therapeutics

Analisis fundamental perusahaan:zevra.com, ZVRA
Produk asil prodhuksi Zevra Corp

For Zevra Therapeutics (ZVRA), which is scaling sales of orphan drugs, profit dynamics are critical during the transition to commercialization. The quarterly EPS growth rate measures the percentage change in net income per share relative to the same period last year. The current value of 2772.80 reflects the efficiency of the operating model. Analysis of this chart allows for the identification of hidden imbalances in US expansion costs. A stable trend confirms the business's resilience to external shocks.

Analisis perusahaan pesaing

JAZZ (Jazz Pharmaceuticals PLC) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cytokinetics Corp (CYTK) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PTC Therapeutics, Inc.|SRRK: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Centessa Corp (CNTA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan DYN (Dyne Therapeutics Inc)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Edgewise Pharma EWTX|Rapport Corp - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ALMS - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Contineum Therapeutics, Inc.|LRMR: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Capricor Therapeutics CAPR|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan TRDA|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Channel PTHS|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MediciNova Inc. (MNOV)|SER - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Apimeds Pharmaceuticals, Inc. - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan AEON Biopharma, Inc.|NLSP (NLS Pharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan BNOX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan FSD Pharma|Wutah bathi EPS kuartalan Reata